Rune Labs Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
39
- Latest Deal Type
-
2ndary - Private
- Investors
-
13
Rune Labs General Information
Description
Developer of a medical platform designed to integrate with neuromodulation therapies to manage data ingestion, labelling, and availability. The company's software platform helps partners in med-tech and pharma to ingest, organize, and analyze large amounts of brain input and output data, all on state-of-the-art secure cloud infrastructure, enabling clients to utilize data from new sensing and stim neuromodulation devices for therapy development and clinical and commercial closed-loop and adaptive therapy applications.
Contact Information
Website
www.runelabs.ioCorporate Office
- 2021 Fillmore Street
- Pmb Suite 1052
- San Francisco, CA 94115
- United States
Corporate Office
- 2021 Fillmore Street
- Pmb Suite 1052
- San Francisco, CA 94115
- United States
Rune Labs Timeline
Rune Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 31-Mar-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 30-Jun-2025 | Completed | Generating Revenue | |||
| 7. Mezzanine | 29-Jan-2025 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 10-Jan-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 29-Nov-2023 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Early Stage VC (Series A) | 16-Sep-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 24-Nov-2020 | $7.3M | Completed | Generating Revenue | ||
| 1. Seed Round | 26-Oct-2020 | $7.3M | $7.3M | Completed | Generating Revenue |
Rune Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 2,194,586 | $0.000010 | $0.14 | $0.14 | 1x | $0.14 | 0.55% | |
| Seed 1 | 5,456,070 | $0.000010 | $0.24 | $0.24 | 1x | $0.24 | 1.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Rune Labs Comparisons
Industry
Financing
Details
Rune Labs Competitors (10)
One of Rune Labs’s 10 competitors is SigTuple, a Venture Capital-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SigTuple | Venture Capital-Backed | Bengaluru, India | ||||
| Savonix | Formerly VC-backed | San Francisco, CA | ||||
| Intheon | Accelerator/Incubator Backed | San Diego, CA | ||||
| Cytek Biosciences | Formerly VC-backed | Fremont, CA | ||||
| Oculogica | Venture Capital-Backed | New Richmond, WI |
Rune Labs Patents
Rune Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4754776-A1 | Artificial-intelligence techniques for forecasting intensity of unintended motor movements | Pending | 28-Jul-2023 | ||
| US-20250037880-A1 | Artificial-intelligence techniques for forecasting intensity of unintended motor movements | Pending | 28-Jul-2023 | ||
| WO-2025029692-A1 | Artificial-intelligence techniques for forecasting intensity of unintended motor movements | Inactive | 28-Jul-2023 | ||
| US-20240122525-A1 | Spinal-cord stimulation techniques for predicting current or future myelination and/or objectively characterizing multiple sclerosis state | Pending | 13-Oct-2022 | ||
| CA-3148648-A1 | Neuromodulation therapy data subject consent matrix | Pending | 20-Aug-2019 | G16H10/60 |
Rune Labs Signals
Rune Labs Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Daybreak Partners | Venture Capital | Minority | ||
| 468 Capital | Venture Capital | Minority | ||
| Samsung NEXT Ventures | Corporate Venture Capital | Minority | ||
| Carnrite Ventures | Venture Capital | Minority | ||
| Eclipse Capital | Venture Capital | Minority |
Rune Labs Acquisitions (1)
Rune Labs’s most recent deal was a Merger/Acquisition with StrivePD. The deal was made on 01-Jan-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| StrivePD | 01-Jan-2019 | Merger/Acquisition | Other Healthcare Technology Systems |
Rune Labs Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| StrivePD | San Anselmo, CA | 2017 |
Rune Labs FAQs
-
When was Rune Labs founded?
Rune Labs was founded in 2018.
-
Where is Rune Labs headquartered?
Rune Labs is headquartered in San Francisco, CA.
-
What is the size of Rune Labs?
Rune Labs has 39 total employees.
-
What industry is Rune Labs in?
Rune Labs’s primary industry is Decision/Risk Analysis.
-
Is Rune Labs a private or public company?
Rune Labs is a Private company.
-
What is Rune Labs’s current revenue?
The current revenue for Rune Labs is .
-
How much funding has Rune Labs raised over time?
Rune Labs has raised $57.4M.
-
Who are Rune Labs’s investors?
Daybreak Partners, 468 Capital, Samsung NEXT Ventures, Carnrite Ventures, and Eclipse Capital are 5 of 13 investors who have invested in Rune Labs.
-
Who are Rune Labs’s competitors?
SigTuple, Savonix, Intheon, Cytek Biosciences, and Oculogica are some of the 10 competitors of Rune Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process